Avita Medical Limited is a biotechnology company which develops and distributes tissue-engineered cellular products for skin replacement. The Company's products include CellSpray and ReCell, which are used for the treatment of burns and other skin injuries, previous scarring, chronic wounds and cosmetic procedures.

Notice under section 708A(5)(e) of the Corporations Act

Notification regarding unquoted securities - AVH

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Avita Medical (AVH AU)

Notice under section 708A(5)(e) of the Corporations Act

Notification regarding unquoted securities - AVH

Statement of CDIs on issue - AVH

Notification of cessation of securities - AVH

AVITA Medical December 2024 Investor Presentation

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)